Inactive Instrument

News Cipher Pharmaceuticals Inc Nasdaq

Equities

CA17253X1050

Summary

Unlock all the news: Be the first to know and act before the market!

Cipher Pharmaceuticals Downgraded to Hold at Stifel GMP Following Share-Price Gains; Price Target Raised to C$9.50	13/05	MT
Transcript : Cipher Pharmaceuticals Inc., Q1 2024 Earnings Call, May 10, 2024	10/05
Cipher Pharmaceuticals : Financial Document	10/05	PU
Cipher Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	10/05	CI
Cipher Pharmaceuticals Reports First Quarter 2024 Results	10/05	AQ
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call	06/05	AQ
Cipher Pharmaceuticals Schedules Q1 2024 Earnings Release and Conference Call	03/05	AQ
Cipher Pharmaceuticals Announces Participation in the 2024 Bloom Burton & Co. Healthcare Investor Conference	03/04	NE
Transcript : Cipher Pharmaceuticals Inc., Q4 2023 Earnings Call, Mar 15, 2024	15/03
Tranche Update on Cipher Pharmaceuticals Inc.'s Equity Buyback Plan announced on November 15, 2023.	15/03	CI
Cipher Pharmaceuticals Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	15/03	CI
Cipher Pharmaceuticals Q4 Profit Falls 61% on Charges	15/03	MT
Cipher Pharmaceuticals Brief: Q4 Net income and earnings per common share were US$7.7 million and $0.32, respectively	15/03	MT
Cipher Pharmaceuticals Brief: Q4 Total revenue was US$4.9 million, consistent with Q4 2022	15/03	MT
Cipher Pharmaceuticals Reports Fourth Quarter and Full Year 2023 Results	15/03	AQ
Cipher Pharmaceuticals Schedules Q4 2023 Earnings Release and Conference Call	08/03	AQ
Cipher Pharmaceuticals Upgraded to Buy at Stifel GMP; Price Target Raised to C$8.00	14/02	MT
Cipher Pharmaceuticals Brief: Announcing that its common shares are now trading on the OTCQX Best Market	29/01	MT
Cipher Pharmaceuticals Announces the Commencement of OTCQX Trading	29/01	AQ
Cipher Pharmaceuticals Announces Change of Auditor	27/11	AQ

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

News Cipher Pharmaceuticals Inc Nasdaq

Equities

CA17253X1050

Summary

Filters